MedTrace Logo

Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis

NCT04085016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2020-10-14

No results posted yet for this study

Summary

This study intends to evaluate the relationship between meibomitis and statin use. Meibomitis is the predominant cause of evaporative dry eye. Higher cholesterol levels were noted in patients with meibomitis when compared to controls without meibomitis. We would like to investigate the effect of statin use on meibomitis among patients with dyslipidemia.

Conditions

  • Meibomian Gland Dysfunction
  • Meibomitis
  • Dyslipidemias

Interventions

DEVICE

Keratograph 5M, Oculus, Wetzlar, Germany

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • I-Jong Wang, MD,PhD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-08
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04085016 on ClinicalTrials.gov